Allogene Therapeutics, Inc. Common Stock (ALLO) is a publicly traded Healthcare sector company. As of August 9, 2026, ALLO trades at $2.01 with a market cap of $693.76M and a P/E ratio of -2.31. ALLO moved +1.78% today. Year to date, ALLO is +46.72%; over the trailing twelve months it is +91.43%. Its 52-week range spans $0.86 to $4.46. Analyst consensus is strong buy with an average price target of $10.00. Rallies surfaces ALLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ALLO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ALLO recently traded at $2.01. Market cap is $693.76M. P/E ratio is -2.31. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $2.01 |
| Market Cap | $693.76M |
| P/E Ratio | -2.31 |
| EPS | $-0.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.46 |
| 52-Week Low | $0.86 |
| Volume | 3.41M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-190.89M |
| Gross Margin | 0.00% |
6 analysts cover ALLO: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.00.